Having validated the value of the MCP-4/MCP-1 ratio as a gender-independent candidate biomarker for PTSD, we next investigated the extent to which any of the individual chemokines might be gender-dependent biomarkers for PTSD. The gene discussed is CCL2; the disease is post-traumatic stress disorder.